We are live on ! Find out more
BPTH

Bio-Path Holdings Inc

Delisted

BPTH was delisted on the 18th of February, 2025.

33 hedge funds and large institutions have $6.02M invested in Bio-Path Holdings Inc in 2017 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 10 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

20% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 10

23% less funds holding

Funds holding: 4333 (-10)

56% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 18

62% less capital invested

Capital invested by funds: $16.1M → $6.02M (-$10M)

Holders
33
Holders Change
-10
Holders Change %
-23.26%
% of All Funds
0.82%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
8
Increased
8
Reduced
10
Closed
18
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Royal Bank of Canada
51
Royal Bank of Canada
Ontario, Canada
-$2.1K -1 Closed
UBS Group
52
UBS Group
Switzerland
-$2.1K -1 Closed

BPTH Hedge Fund Activity: Q2 2017 in Review

33 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Bio-Path Holdings Inc (BPTH) for Q2 2017, worth a combined $6.02M — down 62% from $16.1M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of BPTH and 8 opened new positions — a net loss of 10 holders — while 10 trimmed existing stakes and 8 added.

The largest buyer was Legal & General Group, adding an estimated $912K. The largest seller was BlackRock, cutting an estimated $1.99M.

  • 33 institutional investors held Bio-Path Holdings Inc (BPTH) as of Q2 2017, down from 43 in Q1 2017.
  • Funds reported $6.02M of Bio-Path Holdings Inc stock for Q2 2017, down 62% quarter-over-quarter.
  • 8 funds opened new Bio-Path Holdings Inc positions in Q2 2017 and 18 closed out, a net change of -10 holders.
  • The largest Bio-Path Holdings Inc buyer in Q2 2017 was Legal & General Group, an estimated $912K added.
  • The largest Bio-Path Holdings Inc seller in Q2 2017 was BlackRock, an estimated $1.99M sold.

Based on aggregated 13F filings for Q2 2017.